Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-01-28

AUTHORS

Israel Rubinstein, Richard van Breemen, Daniel G. Nosal, Guy Weinberg, Ronald C. Hershow, Douglas L. Feinstein

ABSTRACT

A recent multi-state outbreak of life-threatening bleeding following inhalation of synthetic cannabinoids has been attributed to contamination with the long-acting anticoagulant rodenticide (LAAR) brodifacoum, a second-generation, highly potent, long-acting derivative of the commonly used blood thinner warfarin. While long-term treatment with high-dose vitamin K1 restores coagulation, it does not affect brodifacoum metabolism or clearance, and, consequently, brodifacoum remains in the human body for several months, thereby predisposing to risk of bleeding recurrence and development of coagulation-independent injury in extrahepatic tissues and fetuses. This has prompted the evaluation of pharmacological measures that accelerate brodifacoum clearance from poisoned patients. Since the induction of certain cytochrome P450 (CYP) enzymes accelerates warfarin metabolism, using CYP inducers, such as phenobarbital, to accelerate brodifacoum clearance seems plausible. However, unlike warfarin, brodifacoum does not undergo significant metabolism in the liver, nor have the effects of phenobarbital on vitamin K1 metabolism been previously determined. In addition, the safety of phenobarbital in brodifacoum-poisoned patients has not been established. Therefore, we propose that CYP inducers should not be used to accelerate the clearance of brodifacoum from poisoned patients, but that alternative approaches such as reducing enterohepatic recirculation of brodifacoum, or using lipid emulsions to scavenge brodifacoum throughout the body, be considered. More... »

PAGES

67-71

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40268-019-0261-4

DOI

http://dx.doi.org/10.1007/s40268-019-0261-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111682506

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30689138


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "4-Hydroxycoumarins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Coagulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 Enzyme Inducers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enterohepatic Circulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fat Emulsions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inactivation, Metabolic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin K", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Jesse Brown VA Medical Center, Chicago, IL USA", 
          "id": "http://www.grid.ac/institutes/grid.280892.9", 
          "name": [
            "University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA", 
            "Jesse Brown VA Medical Center, Chicago, IL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rubinstein", 
        "givenName": "Israel", 
        "id": "sg:person.01152052702.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152052702.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Linus Pauling Institute, Oregon State University, Corvallis, OR USA", 
          "id": "http://www.grid.ac/institutes/grid.4391.f", 
          "name": [
            "Linus Pauling Institute, Oregon State University, Corvallis, OR USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Breemen", 
        "givenName": "Richard", 
        "id": "sg:person.01314335713.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314335713.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Linus Pauling Institute, Oregon State University, Corvallis, OR USA", 
          "id": "http://www.grid.ac/institutes/grid.4391.f", 
          "name": [
            "Linus Pauling Institute, Oregon State University, Corvallis, OR USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nosal", 
        "givenName": "Daniel G.", 
        "id": "sg:person.012015510635.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012015510635.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jesse Brown VA Medical Center, Chicago, IL USA", 
          "id": "http://www.grid.ac/institutes/grid.280892.9", 
          "name": [
            "University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA", 
            "Jesse Brown VA Medical Center, Chicago, IL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weinberg", 
        "givenName": "Guy", 
        "id": "sg:person.0775020332.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775020332.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA", 
          "id": "http://www.grid.ac/institutes/grid.185648.6", 
          "name": [
            "University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hershow", 
        "givenName": "Ronald C.", 
        "id": "sg:person.011471527727.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011471527727.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jesse Brown VA Medical Center, Chicago, IL USA", 
          "id": "http://www.grid.ac/institutes/grid.280892.9", 
          "name": [
            "University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA", 
            "Jesse Brown VA Medical Center, Chicago, IL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feinstein", 
        "givenName": "Douglas L.", 
        "id": "sg:person.01333212067.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333212067.02"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-319-64377-9_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092634004", 
          "https://doi.org/10.1007/978-3-319-64377-9_4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01065653", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024187118", 
          "https://doi.org/10.1007/bf01065653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/253275a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038508864", 
          "https://doi.org/10.1038/253275a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01-28", 
    "datePublishedReg": "2019-01-28", 
    "description": "A recent multi-state outbreak of life-threatening bleeding following inhalation of synthetic cannabinoids has been attributed to contamination with the long-acting anticoagulant rodenticide (LAAR) brodifacoum, a second-generation, highly potent, long-acting derivative of the commonly used blood thinner warfarin. While long-term treatment with high-dose vitamin K1 restores coagulation, it does not affect brodifacoum metabolism or clearance, and, consequently, brodifacoum remains in the human body for several months, thereby predisposing to risk of bleeding recurrence and development of coagulation-independent injury in extrahepatic tissues and fetuses. This has prompted the evaluation of pharmacological measures that accelerate brodifacoum clearance from poisoned patients. Since the induction of certain cytochrome P450 (CYP) enzymes accelerates warfarin metabolism, using CYP inducers, such as phenobarbital, to accelerate brodifacoum clearance seems plausible. However, unlike warfarin, brodifacoum does not undergo significant metabolism in the liver, nor have the effects of phenobarbital on vitamin K1 metabolism been previously determined. In addition, the safety of phenobarbital in brodifacoum-poisoned patients has not been established. Therefore, we propose that CYP inducers should not be used to accelerate the clearance of brodifacoum from poisoned patients, but that alternative approaches such as reducing enterohepatic recirculation of brodifacoum, or using lipid emulsions to scavenge brodifacoum throughout the body, be considered.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40268-019-0261-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2692766", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1020803", 
        "issn": [
          "1174-5886", 
          "1179-6901"
        ], 
        "name": "Drugs in R&D", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "certain cytochrome P450", 
      "CYP inducers", 
      "vitamin K1 metabolism", 
      "safety of phenobarbital", 
      "life-threatening bleeding", 
      "long-term treatment", 
      "effect of phenobarbital", 
      "pharmacological measures", 
      "enterohepatic recirculation", 
      "warfarin metabolism", 
      "extrahepatic tissues", 
      "lipid emulsion", 
      "patients", 
      "P450 inducers", 
      "multi-state outbreak", 
      "significant metabolism", 
      "vitamin K1", 
      "clearance", 
      "synthetic cannabinoids", 
      "warfarin", 
      "cytochrome P450", 
      "phenobarbital", 
      "metabolism", 
      "inducer", 
      "brodifacoum", 
      "bleeding", 
      "recurrence", 
      "inhalation", 
      "injury", 
      "fetuses", 
      "liver", 
      "cannabinoids", 
      "months", 
      "treatment", 
      "risk", 
      "human body", 
      "tissue", 
      "coagulation", 
      "induction", 
      "outbreak", 
      "P450", 
      "safety", 
      "body", 
      "rodenticide brodifacoum", 
      "evaluation", 
      "measures", 
      "effect", 
      "alternative approach", 
      "addition", 
      "development", 
      "K1", 
      "contamination", 
      "derivatives", 
      "recirculation", 
      "approach", 
      "emulsions", 
      "anticoagulant rodenticide brodifacoum", 
      "recent multi-state outbreak", 
      "blood thinner warfarin", 
      "thinner warfarin", 
      "high-dose vitamin K1", 
      "brodifacoum metabolism", 
      "coagulation-independent injury", 
      "brodifacoum clearance", 
      "K1 metabolism", 
      "brodifacoum-poisoned patients", 
      "clearance of brodifacoum", 
      "Accelerate Clearance"
    ], 
    "name": "Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?", 
    "pagination": "67-71", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111682506"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40268-019-0261-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30689138"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40268-019-0261-4", 
      "https://app.dimensions.ai/details/publication/pub.1111682506"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_821.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40268-019-0261-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40268-019-0261-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40268-019-0261-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40268-019-0261-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40268-019-0261-4'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      22 PREDICATES      108 URIs      97 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40268-019-0261-4 schema:about N111f55d210e541139fee9fc0ed1d8657
2 N1d7a9219d4c044a99e957931e1a1acca
3 N49b4bbbc11e14d849a41be62746482d9
4 N7f175c59f25449989ab71662890d5839
5 N906c1c86fcd341f6988ab640d71bc009
6 Na7592b56ebd84ea0a0830debb62193c1
7 Nad9f91c5f50446c793dc64924e2dc6c0
8 Nadfd5e9907294dfb83b82c97c45b5f9c
9 Nb1a8a949481f4caca8ba691236a587eb
10 Ne5ae6dce5c1d463cae833840a3248de1
11 Nfabb2de37ad44098b708e2470711c948
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author Ndce86dbc5bb44ee5aa774c015fdce29c
15 schema:citation sg:pub.10.1007/978-3-319-64377-9_4
16 sg:pub.10.1007/bf01065653
17 sg:pub.10.1038/253275a0
18 schema:datePublished 2019-01-28
19 schema:datePublishedReg 2019-01-28
20 schema:description A recent multi-state outbreak of life-threatening bleeding following inhalation of synthetic cannabinoids has been attributed to contamination with the long-acting anticoagulant rodenticide (LAAR) brodifacoum, a second-generation, highly potent, long-acting derivative of the commonly used blood thinner warfarin. While long-term treatment with high-dose vitamin K1 restores coagulation, it does not affect brodifacoum metabolism or clearance, and, consequently, brodifacoum remains in the human body for several months, thereby predisposing to risk of bleeding recurrence and development of coagulation-independent injury in extrahepatic tissues and fetuses. This has prompted the evaluation of pharmacological measures that accelerate brodifacoum clearance from poisoned patients. Since the induction of certain cytochrome P450 (CYP) enzymes accelerates warfarin metabolism, using CYP inducers, such as phenobarbital, to accelerate brodifacoum clearance seems plausible. However, unlike warfarin, brodifacoum does not undergo significant metabolism in the liver, nor have the effects of phenobarbital on vitamin K1 metabolism been previously determined. In addition, the safety of phenobarbital in brodifacoum-poisoned patients has not been established. Therefore, we propose that CYP inducers should not be used to accelerate the clearance of brodifacoum from poisoned patients, but that alternative approaches such as reducing enterohepatic recirculation of brodifacoum, or using lipid emulsions to scavenge brodifacoum throughout the body, be considered.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree true
24 schema:isPartOf N2c02b77af76746829143d0fc77b1f22e
25 N8b8136ee2b0341a1a89f1d6123c91bfb
26 sg:journal.1020803
27 schema:keywords Accelerate Clearance
28 CYP inducers
29 K1
30 K1 metabolism
31 P450
32 P450 inducers
33 addition
34 alternative approach
35 anticoagulant rodenticide brodifacoum
36 approach
37 bleeding
38 blood thinner warfarin
39 body
40 brodifacoum
41 brodifacoum clearance
42 brodifacoum metabolism
43 brodifacoum-poisoned patients
44 cannabinoids
45 certain cytochrome P450
46 clearance
47 clearance of brodifacoum
48 coagulation
49 coagulation-independent injury
50 contamination
51 cytochrome P450
52 derivatives
53 development
54 effect
55 effect of phenobarbital
56 emulsions
57 enterohepatic recirculation
58 evaluation
59 extrahepatic tissues
60 fetuses
61 high-dose vitamin K1
62 human body
63 inducer
64 induction
65 inhalation
66 injury
67 life-threatening bleeding
68 lipid emulsion
69 liver
70 long-term treatment
71 measures
72 metabolism
73 months
74 multi-state outbreak
75 outbreak
76 patients
77 pharmacological measures
78 phenobarbital
79 recent multi-state outbreak
80 recirculation
81 recurrence
82 risk
83 rodenticide brodifacoum
84 safety
85 safety of phenobarbital
86 significant metabolism
87 synthetic cannabinoids
88 thinner warfarin
89 tissue
90 treatment
91 vitamin K1
92 vitamin K1 metabolism
93 warfarin
94 warfarin metabolism
95 schema:name Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
96 schema:pagination 67-71
97 schema:productId N2052d90c02d04f658931a7f4d45afe2b
98 N3eb7f2510be94c969ae806135f29ea7d
99 Ncdfcb7ff4f3e47d09da3d07acb2ccbe7
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111682506
101 https://doi.org/10.1007/s40268-019-0261-4
102 schema:sdDatePublished 2021-12-01T19:44
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N61c1326440484d8fba21bdd036777a14
105 schema:url https://doi.org/10.1007/s40268-019-0261-4
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N06259668e96e40c5b34ac2c84ca051ef rdf:first sg:person.012015510635.83
110 rdf:rest Nfa13094656f34c41a4db5c9755328b0b
111 N111f55d210e541139fee9fc0ed1d8657 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Enterohepatic Circulation
113 rdf:type schema:DefinedTerm
114 N1d7a9219d4c044a99e957931e1a1acca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Hemorrhage
116 rdf:type schema:DefinedTerm
117 N2052d90c02d04f658931a7f4d45afe2b schema:name doi
118 schema:value 10.1007/s40268-019-0261-4
119 rdf:type schema:PropertyValue
120 N2c02b77af76746829143d0fc77b1f22e schema:issueNumber 1
121 rdf:type schema:PublicationIssue
122 N3eb7f2510be94c969ae806135f29ea7d schema:name pubmed_id
123 schema:value 30689138
124 rdf:type schema:PropertyValue
125 N49b4bbbc11e14d849a41be62746482d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Blood Coagulation
127 rdf:type schema:DefinedTerm
128 N61c1326440484d8fba21bdd036777a14 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N631606c81ee949cd9a58dec520fec150 rdf:first sg:person.011471527727.32
131 rdf:rest Nb89fe05110c847278906f70b76be35c8
132 N7d5a6fe04dec4099be7f34184b4703a3 rdf:first sg:person.01314335713.28
133 rdf:rest N06259668e96e40c5b34ac2c84ca051ef
134 N7f175c59f25449989ab71662890d5839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Inactivation, Metabolic
136 rdf:type schema:DefinedTerm
137 N8b8136ee2b0341a1a89f1d6123c91bfb schema:volumeNumber 19
138 rdf:type schema:PublicationVolume
139 N906c1c86fcd341f6988ab640d71bc009 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Half-Life
141 rdf:type schema:DefinedTerm
142 Na7592b56ebd84ea0a0830debb62193c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Vitamin K
144 rdf:type schema:DefinedTerm
145 Nad9f91c5f50446c793dc64924e2dc6c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Cytochrome P-450 Enzyme Inducers
147 rdf:type schema:DefinedTerm
148 Nadfd5e9907294dfb83b82c97c45b5f9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Fat Emulsions, Intravenous
150 rdf:type schema:DefinedTerm
151 Nb1a8a949481f4caca8ba691236a587eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 Nb89fe05110c847278906f70b76be35c8 rdf:first sg:person.01333212067.02
155 rdf:rest rdf:nil
156 Ncdfcb7ff4f3e47d09da3d07acb2ccbe7 schema:name dimensions_id
157 schema:value pub.1111682506
158 rdf:type schema:PropertyValue
159 Ndce86dbc5bb44ee5aa774c015fdce29c rdf:first sg:person.01152052702.23
160 rdf:rest N7d5a6fe04dec4099be7f34184b4703a3
161 Ne5ae6dce5c1d463cae833840a3248de1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name 4-Hydroxycoumarins
163 rdf:type schema:DefinedTerm
164 Nfa13094656f34c41a4db5c9755328b0b rdf:first sg:person.0775020332.74
165 rdf:rest N631606c81ee949cd9a58dec520fec150
166 Nfabb2de37ad44098b708e2470711c948 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Anticoagulants
168 rdf:type schema:DefinedTerm
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
173 schema:name Pharmacology and Pharmaceutical Sciences
174 rdf:type schema:DefinedTerm
175 sg:grant.2692766 http://pending.schema.org/fundedItem sg:pub.10.1007/s40268-019-0261-4
176 rdf:type schema:MonetaryGrant
177 sg:journal.1020803 schema:issn 1174-5886
178 1179-6901
179 schema:name Drugs in R&D
180 schema:publisher Springer Nature
181 rdf:type schema:Periodical
182 sg:person.011471527727.32 schema:affiliation grid-institutes:grid.185648.6
183 schema:familyName Hershow
184 schema:givenName Ronald C.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011471527727.32
186 rdf:type schema:Person
187 sg:person.01152052702.23 schema:affiliation grid-institutes:grid.280892.9
188 schema:familyName Rubinstein
189 schema:givenName Israel
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152052702.23
191 rdf:type schema:Person
192 sg:person.012015510635.83 schema:affiliation grid-institutes:grid.4391.f
193 schema:familyName Nosal
194 schema:givenName Daniel G.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012015510635.83
196 rdf:type schema:Person
197 sg:person.01314335713.28 schema:affiliation grid-institutes:grid.4391.f
198 schema:familyName van Breemen
199 schema:givenName Richard
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314335713.28
201 rdf:type schema:Person
202 sg:person.01333212067.02 schema:affiliation grid-institutes:grid.280892.9
203 schema:familyName Feinstein
204 schema:givenName Douglas L.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333212067.02
206 rdf:type schema:Person
207 sg:person.0775020332.74 schema:affiliation grid-institutes:grid.280892.9
208 schema:familyName Weinberg
209 schema:givenName Guy
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775020332.74
211 rdf:type schema:Person
212 sg:pub.10.1007/978-3-319-64377-9_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092634004
213 https://doi.org/10.1007/978-3-319-64377-9_4
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/bf01065653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024187118
216 https://doi.org/10.1007/bf01065653
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/253275a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038508864
219 https://doi.org/10.1038/253275a0
220 rdf:type schema:CreativeWork
221 grid-institutes:grid.185648.6 schema:alternateName University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA
222 schema:name University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA
223 rdf:type schema:Organization
224 grid-institutes:grid.280892.9 schema:alternateName Jesse Brown VA Medical Center, Chicago, IL USA
225 schema:name Jesse Brown VA Medical Center, Chicago, IL USA
226 University of Illinois, 835 South Wolcott Ave, MC513, E720, Chicago, IL 60612 USA
227 rdf:type schema:Organization
228 grid-institutes:grid.4391.f schema:alternateName Linus Pauling Institute, Oregon State University, Corvallis, OR USA
229 schema:name Linus Pauling Institute, Oregon State University, Corvallis, OR USA
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...